EU indices up | TA focus on Dechra Pharmaceuticals


European stocks report | Associated British Foods | Dechra Pharmaceuticals | Volkswagen | Ageas...

Stocks (2)

Friday, European stocks were broadly lower. The Stoxx Europe 600 Index slid 1.3%, Germany's DAX 30 sank 1.7%, France's CAC 40 and U.K.'s FTSE 100 were down 0.9%.

70% of STOXX 600 constituents traded lower or unchanged Friday.
29% of the shares trade above their 20D MA vs 41% Thursday (below the 20D moving average).
50% of the shares trade above their 200D MA vs 52% Thursday (below the 20D moving average).

The Euro Stoxx 50 Volatility index added 2.7pts to 31.71, a new 52w high.

3mths relative high: Chemicals, Autos
3mths relative low: none

Europe Best 3 sectors
banks, basic resources, automobiles & parts

Europe worst 3 sectors
real estate, technology, utilities

The 10yr Bund yield fell 2bps to -0.49% (below its 20D MA). The 2yr-10yr yield spread fell 1bp to -23bps (below its 20D MA).

GE 07:00: Jul Industrial Production MoM, exp.: 8.9%
UK 08:30: Aug Halifax House Price Idx YoY, exp.: 3.8%
UK 08:30: Aug Halifax House Price Idx MoM, exp.: 1.6%
FR 14:00: 12-Mth BTF auction, exp.: -0.57%
FR 14:00: 6-Mth BTF auction, exp.: -0.58%
FR 14:00: 3-Mth BTF auction, exp.: -0.57%


In Asian trading hours, EUR/USD was little changed at 1.1835 while GBP/USD slipped to 1.3239. USD/JPY was steady at 106.28. 

Spot gold climbed to $1,938 an ounce.

Associated British Foods, a food processing and retailing company, posted a 4Q trading update: "Trading in the fourth quarter in both our food businesses and Primark exceeded our expectations. (...) All Primark stores reopened in May, June and July.  Since reopening we have traded strongly, attracting customers with our value-for-money offering and a welcoming and safe store environment.  Cumulative sales since reopening to the year-end are expected to be £2bn and our adjusted operating profit on an IFRS16 basis for the year, before exceptional items, is now expected to be at least at the top end of the previously advised £300-350m range."

Dechra Pharmaceuticals, a veterinary pharmaceuticals company, released full-year results: "Dechra delivered consolidated revenue of £515.1 million, representing an increase of 6.8% on the prior year. (...) Consolidated underlying operating profit of £128.3 million represents a 0.4% increase on the prior year. (...) Underlying diluted EPS grew by 1.7% to 92.19 pence. (...) The Board is proposing a final dividend of 24.00 pence per share (2019: 22.10 pence per share). Added to the interim dividend of 10.29 pence per share (2019: 9.50 pence per share), this brings the total dividend for the financial year ended 30 June 2020 to 34.29 pence per share (2019: 31.60 pence per share), representing 8.5% growth over the previous year."
From a weekly point of view, the share has broken above a symmetrical triangle following a consolidation area of 2 years. Furthermore, the 200WMA plays a support role. Above the 200WMA at 2400p look for 4000p and 4300p in extension.

Source: GAIN Capital, TradingView

Informa, a business intelligence group, was downgraded to "neutral" from "buy" at Goldman Sachs.

Volkswagen's, an automobile group, Traton is planning to make a fresh bid for U.S. heavy-truck company Navistar International, which it previously offered 2.9 billion dollars, reported Bloomberg citing people familiar with the matter.

Continental, automotive parts manufacturer, was upgraded to "neutral" from "underweight" at JPMorgan.

Hannover Re, a reinsurance group, was upgraded to "overweight" from "underweight" at JPMorgan.

Hapag-Lloyd, a shipping and container transportation company, was upgraded to "hold" from "reduce" at HSBC.

Suez's, an utility company, CEO Bertrand Camus in an interview with French newspaper Le Figaro that "the proposed deal by Veolia is an aberration and destructive for France". He added that the company's share price has been hurt by the coronavirus pandemic, the offer undervalues Suez's assets and is opportunistic.

Sanofi, a pharmaceutical group, will launch an IPO for its drug-ingredients division in the coming months, according to the company's chief in France Olivier Bogillot cited by France Inter radio.

Scor, a reinsurance company, was downgraded to "neutral" from "overweight" at JPMorgan.

Mapfre, a Spanish insurance company, was downgraded to "underweight" from "neutral" at JPMorgan.

Ageas, a Belgian insurance company, confirmed that it was approached recently by BE Group with "an indicative and highly conditional offer" on the company.  The company added that "the Ageas Board of Directors assessed the indicative proposal but considered it not realistic and has decided not to engage".

Swiss Life, an insurance group, was upgraded to "neutral" from "underweight" at JPMorgan.

Build your confidence risk free

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.